HALOZYME REPORTS FIRST QUARTER 2023 FINANCIAL AND OPERATING RESULTS
Go back to HALOZYME REPORTS FIRST QUARTER 2023 FINANCIAL AND OPERATING RESULTS| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 107.65 +0.26 (0.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $107.39 | 52 Week High | $18.39 | |||
| Open | $106.93 | 52 Week Low | $6.96 | |||
| Day High | $107.95 | P/E | N/A | |||
| Day Low | $106.36 | EPS | $-0.58 | |||
| Volume | 245,322 | |||||
